Posted On: 04/24/2013 1:09:20 PM
Post# of 2146
What I don't get is a company like ACTC that has ZERO products in the market, a pipeline that has two potential drugs in only P1 while the rest is in pre-clinical, an OS of over 1.7 BILLION shares, and is trading at .07 just like ELTP? What am I missing?
(0)
(0)
